Slideshow
Author(s):
These apps are designed to improve treatment adherence, language skills, symptom tracking, communication, and other helpful functions.
FDA Action Update, January 2025: Approvals, Clearances, and Designations
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
This Week on NeurologyLive® — February 3, 2024
Neurology Unwrapped: 2024’s Most Intriguing Conversations
NeurologyLive® Friday 5 — January 31, 2024
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the First Half of 2025